Patent Strategy for Personalized Medicine after Bilski

Now that the Supreme Court has invalidated Bilski and Warsaw's business methods patent, many are left wondering how the ruling may affect the personalized medicine industry. The article, Patent Strategy for Personalized Medicine in Light of Bilski, discusses the implications of the Bilski decision on such inventions.

*The perspectives expressed in the Bilski Blog, as well as in various sources cited therein from time to time, are those of the respective authors and do not necessarily represent the views of Fenwick & West LLP or its clients.